References

References

  1. TAMIFLU® (oseltamivir phosphate) Prescribing Information. Nutley, NJ: Roche Laboratories Inc.; November 2006.
  2. Centers for Disease Control and Prevention. Key facts about influenza and the influenza vaccine [CDC Web site]. August 30, 2006. Available at: http://www.cdc.gov/flu/keyfacts.htm. Accessed December 15, 2006.
  3. Centers for Disease Control and Prevention. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2006;55(RR-10):1-42.
  4. Centers for Disease Control and Prevention. Hoyert DL, Heron MP, Murphy SL, Kung HC. Deaths: Final data for 2003. Natl Vital Stat Rep. 2006;54:1-38.
  5. Montalto, NJ. An office-based approach to influenza: clinical diagnosis and laboratory testing. Am Fam Phys. 2003;67:111-118.
  6. Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001;20:127-133.
  7. Poehling KA, Edwards KM, Weinberg GA, et al, for the New Vaccine Surveillance Network. The underrecognized burden of influenza in young children. N Engl J Med. 2006;355:31-40.
  8. Hayden FG, Belshe R, Villanueva C, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis. 2004;189:440-449.
  9. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza. A randomized controlled trial. JAMA. 2000;283:1016-1024.
  10. Ward P, Small I, Smith J, Suter P, Dutkowski R. Oseltamivir (TAMIFLU®) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005;55(suppl 1):i5-i21.
  11. Welliver R, Monto AS, Carewicz O, et al, for the Oseltamivir Post Exposure Prophylaxis Investigator Group. Effectiveness of oseltamivir in preventing influenza in household contacts. A randomized clinical trial. JAMA. 2001;285:748-754.
  12. National Prescription Audit™ and Next Generation Prescription Services™, 1999-present. IMS Health; 2006.

THIS SITE IS INTENDED FOR U.S. AUDIENCES ONLY.

Copyright © 2007 Roche Laboratories Inc. All rights reserved. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Statement.